CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 1 filers reported holding CLOVIS ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 100 | -96.7% | 0.00% | – |
| Q4 2021 | $8,000 | – | 3,015 | +2915.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -75.0% | 100 | -88.9% | 0.00% | – |
| Q4 2020 | $4,000 | -20.0% | 900 | 0.0% | 0.00% | – |
| Q3 2020 | $5,000 | -16.7% | 900 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | +20.0% | 900 | +12.5% | 0.00% | – |
| Q1 2020 | $5,000 | -37.5% | 800 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $8,000 | +166.7% | 800 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | -75.0% | 800 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $12,000 | -42.9% | 800 | -5.8% | 0.00% | -50.0% |
| Q1 2019 | $21,000 | +5.0% | 849 | -26.1% | 0.00% | -33.3% |
| Q4 2018 | $20,000 | – | 1,149 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |